CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
What Is Injectable HIV PrEP? CLINICIANS’ QUICK GUIDE
-
August 2022
-
[PDF-966.18 KB]
Details:
-
Corporate Authors:
-
Description:The US Food and Drug Administration (FDA) has approved one injectable pre-exposure prophylaxis
(PrEP) medication: cabotegravir (CAB) 600 mg (brand name Apretude®). CAB is a single antiretroviral drug given as an intramuscular injection every 2 months to prevent HIV.
In 2021, the US Preventive Services Task Force issued a graded recommendation to prescribe CAB for PrEP to adult patients who are at risk of getting HIV through sex (grade IA).
cdc-lsht-prevention-brochure-clinicians-quick-guide-what-is-injectable-hiv-prep.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Pages in Document:4 unnumbered pages
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
